These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Emergency contraception: a reasonable personal choice or a destructive societal influence? Greene MF Clin Pharmacol Ther; 2008 Jan; 83(1):17-9. PubMed ID: 18165824 [TBL] [Abstract][Full Text] [Related]
5. Emergency contraception update: a Canadian perspective. Leung VW; Soon JA; Levine M Clin Pharmacol Ther; 2008 Jan; 83(1):177-80. PubMed ID: 18043681 [TBL] [Abstract][Full Text] [Related]
6. Long-acting reversible contraception (LARC) use among adolescent females in secondary institutions in Nnewi, Nigeria. Eke AC; Alabi-Isama L J Obstet Gynaecol; 2011; 31(2):164-8. PubMed ID: 21281035 [TBL] [Abstract][Full Text] [Related]
7. Women's awareness of long-acting, reversible contraceptive methods (LARCs) in community family planning clinics and general practice. Mansour D; Rosales C; Cox M Eur J Contracept Reprod Health Care; 2008 Dec; 13(4):396-9. PubMed ID: 19117255 [TBL] [Abstract][Full Text] [Related]
8. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences. Levine JP J Fam Pract; 2004 Nov; 53(11):904-13. PubMed ID: 15527729 [No Abstract] [Full Text] [Related]
10. The decline of laparoscopic sterilisation. Horgan R; Higgins JR; Burke G Ir Med J; 2008 Feb; 101(2):53-5. PubMed ID: 18450251 [TBL] [Abstract][Full Text] [Related]
11. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel. Jick SS; Kaye JA; Russmann S; Jick H Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485 [TBL] [Abstract][Full Text] [Related]
12. Long-acting, reversible and permanent methods of contraception: insight into women's choice of method. Kane R; Irving G; Brown S; Parkes N; Walling M; Killick S Qual Prim Care; 2009; 17(2):107-14. PubMed ID: 19416603 [TBL] [Abstract][Full Text] [Related]
13. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations. Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729 [TBL] [Abstract][Full Text] [Related]
15. Barriers to modern contraceptive use in rural Peru. Tucker GM Stud Fam Plann; 1986; 17(6 Pt 1):308-16. PubMed ID: 3798494 [TBL] [Abstract][Full Text] [Related]
16. An assessment of the first 3 years' use of Implanon in Luton. Agrawal A; Robinson C J Fam Plann Reprod Health Care; 2005 Oct; 31(4):310-2. PubMed ID: 16274557 [TBL] [Abstract][Full Text] [Related]
17. Sexual behaviour, reproductive health and contraceptive use among adolescents and young adults in Mbale District, Uganda. Agyei WK; Mukiza-Gapere J; Epema EJ J Trop Med Hyg; 1994 Aug; 97(4):219-27. PubMed ID: 8064944 [TBL] [Abstract][Full Text] [Related]
19. Prevalence and factors predictive of long-acting reversible contraceptive use in a tertiary hospital in urban Ghana. Dassah ET; Odoi AT; Owusu-Asubonteng G Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):293-9. PubMed ID: 23650905 [TBL] [Abstract][Full Text] [Related]